Enhanced depletion of MLL-fusion proteins in acute leukemia: potential for improved therapeutic outcomes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Enhanced depletion of MLL-fusion proteins in acute leukemia: potential for improved therapeutic outcomes ; volume:13 ; number:1 ; day:16 ; month:8 ; year:2024 ; pages:1-5 ; date:12.2024
Experimental hematology & oncology ; 13, Heft 1 (16.8.2024), 1-5, 12.2024
- Creator
-
Che, Noelia
Cantilena, Sandra
Looi-Somoye, Remi
Sundar, Danesh
Fung, Kent
Boer, Jasper de
Williams, Owen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-024-00556-w
- URN
-
urn:nbn:de:101:1-2411032116579.803036564360
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Che, Noelia
- Cantilena, Sandra
- Looi-Somoye, Remi
- Sundar, Danesh
- Fung, Kent
- Boer, Jasper de
- Williams, Owen
- SpringerLink (Online service)
Other Objects (12)
MLL-r Leukemia
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
A novel spliced fusion of MLL with CT45A2in a pediatric biphenotypic acute leukemia
Progenitor like cell type of an MLL-EDC4 fusion in acute myeloid leukemia
circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression
RNA binding proteins in MLL-rearranged leukemia
MLL oncoprotein levels influence leukemia lineage identities
A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia
IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia
Role of the t(4;11) fusion proteins MLL/AF4 and AF4/MLL for survival and growth of patient-derived xenograft leukemia cells in vivo
Rare MLL-ELL fusion transcripts in childhood acute myeloid leukemia—association with young age and myeloid sarcomas?
How to effectively treat acute leukemia patients bearing MLL-rearrangements ?
MLL-r Leukemia
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
A novel spliced fusion of MLL with CT45A2in a pediatric biphenotypic acute leukemia
Progenitor like cell type of an MLL-EDC4 fusion in acute myeloid leukemia
circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression
RNA binding proteins in MLL-rearranged leukemia
MLL oncoprotein levels influence leukemia lineage identities
A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia
IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia
Role of the t(4;11) fusion proteins MLL/AF4 and AF4/MLL for survival and growth of patient-derived xenograft leukemia cells in vivo
Rare MLL-ELL fusion transcripts in childhood acute myeloid leukemia—association with young age and myeloid sarcomas?
How to effectively treat acute leukemia patients bearing MLL-rearrangements ?
MLL-r Leukemia
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity
A novel spliced fusion of MLL with CT45A2in a pediatric biphenotypic acute leukemia
Progenitor like cell type of an MLL-EDC4 fusion in acute myeloid leukemia
circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression
RNA binding proteins in MLL-rearranged leukemia
MLL oncoprotein levels influence leukemia lineage identities
A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia
IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia
Role of the t(4;11) fusion proteins MLL/AF4 and AF4/MLL for survival and growth of patient-derived xenograft leukemia cells in vivo
Rare MLL-ELL fusion transcripts in childhood acute myeloid leukemia—association with young age and myeloid sarcomas?